JP2024536815A5 - - Google Patents

Info

Publication number
JP2024536815A5
JP2024536815A5 JP2024518277A JP2024518277A JP2024536815A5 JP 2024536815 A5 JP2024536815 A5 JP 2024536815A5 JP 2024518277 A JP2024518277 A JP 2024518277A JP 2024518277 A JP2024518277 A JP 2024518277A JP 2024536815 A5 JP2024536815 A5 JP 2024536815A5
Authority
JP
Japan
Prior art keywords
nitrogen
sulfur
oxygen
heteroatoms independently
independently selected
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024518277A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024536815A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/044437 external-priority patent/WO2023049290A1/en
Publication of JP2024536815A publication Critical patent/JP2024536815A/ja
Publication of JP2024536815A5 publication Critical patent/JP2024536815A5/ja
Pending legal-status Critical Current

Links

JP2024518277A 2021-09-23 2022-09-22 β-アドレナリンアゴニスト及びその使用方法 Pending JP2024536815A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163247727P 2021-09-23 2021-09-23
US63/247,727 2021-09-23
PCT/US2022/044437 WO2023049290A1 (en) 2021-09-23 2022-09-22 Beta adrenergic agonist and methods of using the same

Publications (2)

Publication Number Publication Date
JP2024536815A JP2024536815A (ja) 2024-10-08
JP2024536815A5 true JP2024536815A5 (cg-RX-API-DMAC7.html) 2025-09-19

Family

ID=85721126

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024518277A Pending JP2024536815A (ja) 2021-09-23 2022-09-22 β-アドレナリンアゴニスト及びその使用方法

Country Status (9)

Country Link
US (1) US20240270701A1 (cg-RX-API-DMAC7.html)
EP (1) EP4404924A4 (cg-RX-API-DMAC7.html)
JP (1) JP2024536815A (cg-RX-API-DMAC7.html)
KR (1) KR20240109240A (cg-RX-API-DMAC7.html)
CN (1) CN117999072A (cg-RX-API-DMAC7.html)
AU (1) AU2022350660A1 (cg-RX-API-DMAC7.html)
CA (1) CA3230482A1 (cg-RX-API-DMAC7.html)
MX (1) MX2024003481A (cg-RX-API-DMAC7.html)
WO (1) WO2023049290A1 (cg-RX-API-DMAC7.html)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4147799A (en) * 1971-06-24 1979-04-03 Kyowa Hakko Kogyo Co., Ltd. Process for reducing blood pressure and blocking β-adrenergic receptor
US4082847A (en) * 1976-12-06 1978-04-04 Merck & Co., Inc. Substituted aminoethanols and pharmaceutical use
AU576322B2 (en) * 1983-07-22 1988-08-25 Ici Australia Limited Alpha-substituted-alpha-cyanomethyl alcohols
US6525202B2 (en) * 2000-07-17 2003-02-25 Wyeth Cyclic amine phenyl beta-3 adrenergic receptor agonists
ES2257152B1 (es) * 2004-05-31 2007-07-01 Laboratorios Almirall S.A. Combinaciones que comprenden agentes antimuscarinicos y agonistas beta-adrenergicos.
US20070021421A1 (en) * 2005-07-25 2007-01-25 Hampton Thomas G Measurement of gait dynamics and use of beta-blockers to detect, prognose, prevent and treat amyotrophic lateral sclerosis
US20100009934A1 (en) * 2008-06-09 2010-01-14 Combinatorx, Incorporated Beta adrenergic receptor agonists for the treatment of b-cell proliferative disorders
JP7682097B2 (ja) * 2019-03-27 2025-05-23 キュラセン セラピューティクス インコーポレイテッド ベータアドレナリンアゴニスト及びそれを使用する方法
TWI877182B (zh) * 2019-07-01 2025-03-21 美商古拉森療法公司 β腎上腺素激動劑及其使用方法

Similar Documents

Publication Publication Date Title
JP2022527769A5 (cg-RX-API-DMAC7.html)
RU2129556C1 (ru) Производное дигидробензопирана, обладающее сосудосуживающим действием, промежуточные соединения, способы получения, фармацевтическая композиция и способ ее получения
RU2014145682A (ru) Органические соединения
EA005520B1 (ru) Карбаматы, полученные из арилалкиламинов
JP2022000450A (ja) テトラヒドロナフタレン誘導体
US9682950B2 (en) Thiophene-2-carboximidamide based selective neuronal nitric oxide synthase inhibitors
PT98641B (pt) Processo para a preparacao de 2-amino-1,2,3,4-tetrahidronaftlalenos 3-aminocromanos substituidos no anel
ES2309514T3 (es) Derivados de 4-(2-fenilsufanil-fenil)-piperidina como inhibidores de la recaptacion de serotonina.
JP2023123607A (ja) ベンゼン誘導体
RU2149158C1 (ru) Производные 2-амино-1,2,3,4-тетрагидронафталина, обладающие активностью в отношении сердечно-сосудистой системы, и фармацевтическая композиция
JPWO2016088834A1 (ja) ジヒドロナフタレン誘導体
JP2002526527A (ja) タキキニン受容体拮抗剤としてのナフタレンカルボキシアミド
RU2016144410A (ru) Позитивные аллостерические модуляторы никотинового рецептора ацетилхолина
KR20070091210A (ko) 글리신 수송 억제제
JP2024536815A5 (cg-RX-API-DMAC7.html)
JPH11509848A (ja) N−(4−置換−ベンジル)−2−アミノラクタム誘導体
JP2018002662A (ja) キノリルピロロピリミジル縮合環化合物を合成するために有用な中間体
JP2023552292A5 (cg-RX-API-DMAC7.html)
RU2007125658A (ru) Фенилпиперазиновые производные с сочетанием свойств неполного агонизма к рецепторам дофамина-d2 и ингибирования повторного поглощения серотонина
JP2023541375A5 (cg-RX-API-DMAC7.html)
JP2025512777A5 (cg-RX-API-DMAC7.html)
HU187789B (en) Process for preparing 2-amino-1,2,3,4-tetrahydro-naphtalena derivatives
JP7766782B2 (ja) ビタミンd誘導体の結晶又はその溶媒和物の結晶
KR20040091119A (ko) 키랄 1,4-이치환된 피페라진의 제조방법
MX2009002361A (es) Derivados de feniloxianilina.